Levamisole (Ergamisol)
Revision as of 18:54, 11 June 2023 by Jwarner (talk | contribs) (→History of changes in FDA indication)
This agent is not commercially available in the United States and is included for historic purposes only.
Diseases for which it was used
History of changes in FDA indication
- 1990-06-18: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & SWOG S8591)
Also known as
- Brand name: Ergamisol